Isothermal Nucleic Acid Amplification Technology Market

Isothermal Nucleic Acid Amplification Technology Market contains market size and forecasts of Isothermal Nucleic Acid Amplification Technology (INAAT) in Global, including the following market information:

• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Isothermal Nucleic Acid Amplification Technology (INAAT) market was valued at 531.5 million in 2021 and is projected to reach US$ 995.4 million by 2028, at a CAGR of 9.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Isothermal Nucleic Acid Amplification Technology (INAAT) include Grifols, Hologic, Abbott Laboratories, BD, Meridian Bioscience, Eiken Chemical, Quidel Corporation, QIAGEN and bioMerieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Isothermal Nucleic Acid Amplification Technology (INAAT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segment Percentages, by Type, 2021 (%)

by Technology

• Loop-mediated Isothermal Amplification
• Nucleic Acid Sequence-based Amplification
• Rolling Circle Amplification
• Single Primer Isothermal Amplification
• Helicase-dependent Isothermal DNA Amplification
• Recombinase Polymerase Amplification
• Strand Displacement Amplification

by Product Type

• Assay
• Kits
• Reagents

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segment Percentages, by Application, 2021 (%)

• Infectious Disease Diagnosis
• Blood Screening
• Cancer Diagnosis
• Cancer Research and Laboratory Research
• Other

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Isothermal Nucleic Acid Amplification Technology (INAAT) revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Isothermal Nucleic Acid Amplification Technology (INAAT) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Grifols
• Hologic
• Abbott Laboratories
• BD
• Meridian Bioscience
• Eiken Chemical
• Quidel Corporation
• QIAGEN
• bioMerieux
• Tecan
• DiaSorin
• Thermo Fisher Scientific
• Illumina
• New England Biolabs
• TwistDx
• Mast Group
• Lucigen Corporation
• Ustar Biotechnologies
• Genomtec
• Jena Bioscience
• OptiGene
• Sysmex Corporation
• Premier Biosoft
• mFluiDx
• Cangene